EUVIMEDSkopri EUVIMED
Open access

APOE + macrophages and POSTN + CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma

Qintao Ge iD, Shengdong Ge iD, Zhongyuan Wang iD, Aihetaimujiang Anwaier iD, Jiahe Lu iD, Xi Tian iD, Yue Wang, Jianfeng Yang iD, Yonghao Chen iD, Hailiang Zhang iD, Dingwei Ye iD, Shan-Chao Zhao iD and 1 more

Science Advances · 2026-08-07 · 12 (32)

DOI: 10.1126/sciadv.aed0733 ↗

At a glance

Journal article in Science Advances, published on 2026-08-07. Written by Qintao Ge and 12 co-authors. Institution: Department of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College; Qingdao Institute of Life Sciences,…. Major MEDLINE topics: Kidney Neoplasms, Carcinoma, Renal Cell, Apolipoproteins E, Macrophages. Cited 2 times so far (Crossref); 63 references. The full text is freely available in PubMed Central. Funded by: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Natural Science Foundation of Shanghai.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Tumor immune barriers (TIBs) are spatially organized stromal-immune niches that restrict lymphocyte entry. To explain persistent immune-checkpoint blockade (ICB) resistance in clear cell renal cell carcinoma (ccRCC), we mapped TIBs and defined a peritumoral variant built from POSTN + cancer-associated fibroblasts (CAFs) interlaced with APOE + tumor-associated macrophages (TAMs). This niche excluded CD8 + T cells from tumor cores, and was enriched in poor-prognosis, ICB-refractory patients. Spatial transcriptomics and single-cell profiling showed TIB regions enriched for extracellular-matrix remodeling, immunosuppressive ligand-receptor circuits, and metabolic reprogramming. Mechanistically, tumor-derived TGF-β1 activated CAFs via SMAD signaling, inducing POSTN and recruiting APOE + TAMs through integrin and chemokine axes. TAMs secreted TGF-β1 and VEGFA, amplifying stromal programs and sustaining exclusion. Blocking POSTN reprogrammed macrophages, reduced matrix-mediated suppression, and restored CD8 + infiltration. In vivo, POSTN inhibition combined with ICB boosted antitumor immunity, reduced tumor burden, and reversed immunosuppressive infiltration, nominating POSTN-directed strategies to potentiate ICB.

Subjects

MeSH terms (MEDLINE)

Kidney NeoplasmsCarcinoma, Renal CellApolipoproteins EMacrophagesCancer-Associated FibroblastsTumor-Associated MacrophagesDrug Resistance, NeoplasmPeriostinHumansAnimalsMiceTumor MicroenvironmentTransforming Growth Factor beta1ImmunotherapyImmune Checkpoint InhibitorsCell Adhesion Molecules

Substances

PeriostinPOSTN protein, humanApolipoproteins ETransforming Growth Factor beta1Immune Checkpoint InhibitorsCell Adhesion Molecules

Authors and institutions

  • Department of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College; Qingdao Institute of Life Sciences, Fudan University, Shanghai, 200032, P.R. China.
  • Shanghai Genitourinary Cancer Institute, Shanghai, 200032 P.R. China.
  • Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, 510900, China.
  • Department of Urology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, P.R. China.
  • West China Medical Center of Sichuan University, Chengdu, Sichuan, 610000, P.R. China.
  • Department of Urology, Huadong Hospital, Fudan University, Shanghai 200030, China.

ORCID profiles: Qintao Ge, Shengdong Ge, Zhongyuan Wang, Aihetaimujiang Anwaier, Jiahe Lu, Xi Tian, Jianfeng Yang, Yonghao Chen, Hailiang Zhang, Dingwei Ye, Shan-Chao Zhao, Wenhao Xu

Funding

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Shanghai
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • Shanghai Hospital Development Center
  • Beijing Xisike Clinical Oncology Research Foundation
  • Zhongnanshan Medical Foundation of Guangdong Province

Cite

APA

Ge, Q., Ge, S., Wang, Z., Anwaier, A., Lu, J., Tian, X., Wang, Y., Yang, J., Chen, Y., Zhang, H., Ye, D., Zhao, S. C., & Xu, W. (2026). APOE + macrophages and POSTN + CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma. Science Advances. https://doi.org/10.1126/sciadv.aed0733

Vancouver

Ge Q, Ge S, Wang Z, Anwaier A, Lu J, Tian X, et al. APOE + macrophages and POSTN + CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma. Science Advances. 2026. doi:10.1126/sciadv.aed0733

BibTeX
@article{Ge2026,
  author = {Ge, Qintao and Ge, Shengdong and Wang, Zhongyuan and Anwaier, Aihetaimujiang and Lu, Jiahe and Tian, Xi and Wang, Yue and Yang, Jianfeng and Chen, Yonghao and Zhang, Hailiang and Ye, Dingwei and Zhao, Shan-Chao and Xu, Wenhao},
  title = {APOE + macrophages and POSTN + CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aed0733}
}
Start for free →